META-ANALYSIS OF THE MODERATING EFFECT OF RS1799971 IN OPRM1, THE MU-OPIOID RECEPTOR GENE, ON NALTREXONE RESPONSE IN ALCOHOL TREATMENT

被引:0
|
作者
Hartwell, E. E.
Feinn, R.
Morris, P.
Anton, R. F.
Gelertner, J.
Krystal, J.
Arias, A. J.
Oslin, D.
Schacht, J. P.
Homan, M.
Petrakis, I.
Gueorguieva, R.
Kranzler, H. R.
机构
[1] Cpl Michael J Crescenz VAMC, Mental Illness Res Educ & Clin Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Psychiat, Ctr Studies Addict, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
120
引用
收藏
页码:40A / 40A
页数:1
相关论文
共 50 条
  • [1] Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder
    Hartwell, Emily E.
    Feinn, Richard
    Morris, Paige E.
    Gelernter, Joel
    Krystal, John
    Arias, Albert J.
    Hoffman, Michaela
    Petrakis, Ismene
    Gueorguieva, Ralitza
    Schacht, Joseph P.
    Oslin, David
    Anton, Raymond F.
    Kranzler, Henry R.
    ADDICTION, 2020, 115 (08) : 1426 - 1437
  • [2] OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis
    Haerian, Batoul Sadat
    Haerian, Monir Sadat
    PHARMACOGENOMICS, 2013, 14 (07) : 813 - 824
  • [3] An analysis of the effect of mu-opioid receptor gene (OPRM1) promoter region DNA methylation on the response of naltrexone treatment of alcohol dependence
    Yufei Lin
    Henry R. Kranzler
    Lindsay A. Farrer
    Hongqin Xu
    David C. Henderson
    Huiping Zhang
    The Pharmacogenomics Journal, 2020, 20 : 672 - 680
  • [4] An analysis of the effect of mu-opioid receptor gene (OPRM1) promoter region DNA methylation on the response of naltrexone treatment of alcohol dependence
    Lin, Yufei
    Kranzler, Henry R.
    Farrer, Lindsay A.
    Xu, Hongqin
    Henderson, David C.
    Zhang, Huiping
    PHARMACOGENOMICS JOURNAL, 2020, 20 (05): : 672 - 680
  • [5] PHARMACOEPIGENETICS OF ALCOHOL DEPENDENCE: NO SIGNIFICANT EFFECT OF MU-OPIOID RECEPTOR GENE (OPRM1) PROMOTER METHYLATION ON NALTREXONE TREATMENT RESPONSE
    Lin, Yufei
    Kranzler, Henry
    Farrer, Lindsay
    Henderson, David
    Zhang, Huiping
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1186 - 1186
  • [6] Lack of associations of the opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with alcohol dependence: review and meta-analysis of retrospective controlled studies
    Kong, Xiangyi
    Deng, Hao
    Gong, Shun
    Alston, Theodore
    Kong, Yanguo
    Wang, Jingping
    BMC MEDICAL GENETICS, 2017, 18
  • [7] Association of opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with nicotine dependence
    Kong, Xiangyi
    Deng, Hao
    Alston, Theodore
    Kong, Yanguo
    Wang, Jingping
    ONCOTARGET, 2017, 8 (48): : 84329 - 84337
  • [8] Opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) and postoperative nausea and vomiting
    Kong, Yanguo
    Yan, Tao
    Gong, Shun
    Deng, Hao
    Zhang, Guohua
    Wang, Jingping
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (09): : 2764 - 2780
  • [9] Association of μ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis
    Chamorro, Antonio-Javier
    Marcos, Miguel
    Miron-Canelo, Jose-Antonio
    Pastor, Isabel
    Gonzalez-Sarmiento, Rogelio
    Laso, Francisco-Javier
    ADDICTION BIOLOGY, 2012, 17 (03) : 505 - 512
  • [10] Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response
    Xie, Xiaohu
    Gu, Jun
    Zhuang, Dingding
    Zhou, Yun
    Chen, Xiaoyu
    Shen, Wenwen
    Li, Longhui
    Liu, Yue
    Xu, Wenjin
    Hong, Qingxiao
    Xu, Zemin
    Chen, Weisheng
    Zhou, Wenhua
    Liu, Huifen
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (11)